rs140403186

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_005529.7(HSPG2):ā€‹c.12004C>Gā€‹(p.Leu4002Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000844 in 1,540,970 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0045 ( 5 hom., cov: 33)
Exomes š‘“: 0.00045 ( 6 hom. )

Consequence

HSPG2
NM_005529.7 missense

Scores

10
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 7.51
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), HSPG2. . Gene score misZ 1.1367 (greater than the threshold 3.09). Trascript score misZ 3.3999 (greater than threshold 3.09). GenCC has associacion of gene with Silverman-Handmaker type dyssegmental dysplasia, Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.012234807).
BP6
Variant 1-21829068-G-C is Benign according to our data. Variant chr1-21829068-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 198971.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00445 (678/152354) while in subpopulation AFR AF= 0.0156 (648/41580). AF 95% confidence interval is 0.0146. There are 5 homozygotes in gnomad4. There are 315 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HSPG2NM_005529.7 linkuse as main transcriptc.12004C>G p.Leu4002Val missense_variant 88/97 ENST00000374695.8 NP_005520.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HSPG2ENST00000374695.8 linkuse as main transcriptc.12004C>G p.Leu4002Val missense_variant 88/971 NM_005529.7 ENSP00000363827 P1
HSPG2ENST00000486901.1 linkuse as main transcriptn.1343C>G non_coding_transcript_exon_variant 2/112

Frequencies

GnomAD3 genomes
AF:
0.00445
AC:
677
AN:
152236
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0156
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.000965
AC:
136
AN:
140868
Hom.:
1
AF XY:
0.000658
AC XY:
50
AN XY:
75938
show subpopulations
Gnomad AFR exome
AF:
0.0158
Gnomad AMR exome
AF:
0.000530
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000443
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000373
Gnomad OTH exome
AF:
0.000713
GnomAD4 exome
AF:
0.000449
AC:
623
AN:
1388616
Hom.:
6
Cov.:
33
AF XY:
0.000372
AC XY:
255
AN XY:
685158
show subpopulations
Gnomad4 AFR exome
AF:
0.0170
Gnomad4 AMR exome
AF:
0.000617
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000253
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000464
Gnomad4 OTH exome
AF:
0.000935
GnomAD4 genome
AF:
0.00445
AC:
678
AN:
152354
Hom.:
5
Cov.:
33
AF XY:
0.00423
AC XY:
315
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0156
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00122
Hom.:
0
Bravo
AF:
0.00510
ESP6500AA
AF:
0.0144
AC:
59
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000764
AC:
66
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 04, 2015- -
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 08, 2020- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 20, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 28, 2016- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 10, 2015- -
Lethal Kniest-like syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
HSPG2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 22, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Schwartz-Jampel syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
1.5
L
MutationTaster
Benign
0.99
D
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.38
Sift
Uncertain
0.013
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.49
MVP
0.69
MPC
0.78
ClinPred
0.023
T
GERP RS
4.0
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.2
Varity_R
0.092
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140403186; hg19: chr1-22155561; API